Dermata Therapeutics announces over 1,000 orders for its new skin renewal treatment, Tome Foundational Treatment, since its launch.
| Name | Dermata Therapeutics, Inc. |
|---|---|
| CIK | 0001853816 |
| Tickers | DRMA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | <br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (858)-223-0882 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Dermata Therapeutics announces over 1,000 orders for its new skin renewal treatment, Tome Foundational Treatment, since its launch.
Dermata Therapeutics shares its Q3 2026 financial results, outlining performance and strategic initiatives in the pharmaceutical preparations sector.
Bigger Capital Fund and District 2 Capital increase their stakes in Dermata Therapeutics, reflecting growing interest in the pharmaceutical preparations sector.
Dermata Therapeutics announces the enrollment of the first participant in a clinical trial for its acne treatment, Tome Clearing Treatment, expected to launch in 2027.
Dermata Therapeutics files a prospectus for the resale of 6.9 million shares, indicating a strategic shift towards skincare solutions.
Dermata Therapeutics, Inc. secures effectiveness for its S-3 registration statement, paving the way for future capital-raising efforts.
374 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-17 | 8-K | 8-K | 8.01 | 0001493152-26-052715 | 001-40739 | 261564060 | 34 | 199883 | 1 | 1 |
| 2026-11-10 | 10-Q | 10-Q | 0001493152-26-050967 | 001-40739 | 261540352 | 34 | 6135404 | 1 | 1 | |
| 2026-11-10 | 8-K | 8-K | 2.02,9.01 | 0001493152-26-050964 | 001-40739 | 261540314 | 34 | 340771 | 1 | 1 |
| 2026-11-02 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000921895-26-002901 | 005-92822 | 261512898 | 34 | 33812 | |||
| 2026-10-29 | 8-K | 8-K | 8.01 | 0001493152-26-049312 | 001-40739 | 261502972 | 34 | 204352 | 1 | 1 |
| 2026-10-21 | 424B3 | 424B3 | 0001493152-26-047911 | 333-299391 | 261476054 | 33 | 176486 | |||
| 2026-10-20 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003304 | 333-299391 | 261474063 | 33 | 1740 | ||
| 2026-10-09 | S-3 | S-3 | 0001493152-26-046518 | 333-299391 | 261452955 | 33 | 445999 | 1 | 1 | |
| 2026-08-18 | 4 | 4 | 0001493152-26-039048 | 22677 | ||||||
| 2026-08-18 | 4 | 4 | 0001493152-26-039046 | 11347 | ||||||
| 2026-08-17 | 25-NSE | xslF25X02/primary_doc.xml | 0001354457-26-000799 | 001-40739 | 261286936 | 34 | 2976 | |||
| 2026-08-17 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001493152-26-038647 | 001-40739 | 261284920 | 34 | 1157502 | 1 | 1 |
| 2026-08-11 | 10-Q | 10-Q | 0001493152-26-037127 | 001-40739 | 261263204 | 34 | 5389920 | 1 | 1 | |
| 2026-08-11 | 8-K | 8-K | 2.02,9.01 | 0001493152-26-037124 | 001-40739 | 261263172 | 34 | 321101 | 1 | 1 |
| 2026-08-05 | 8-K | 8-K | 8.01 | 0001493152-26-036109 | 001-40739 | 261241452 | 34 | 252997 | 1 | 1 |
| 2026-06-16 | 4 | 4 | 0001493152-26-028884 | 5393 | ||||||
| 2026-06-04 | S-8 | S-8 | 0001493152-26-027275 | 333-296494 | 261065179 | 33 | 350560 | 1 | 1 | |
| 2026-06-01 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001493152-26-026642 | 005-92822 | 261051595 | 34 | 12494 | |||
| 2026-05-29 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001810 | 333-291740 | 261046917 | 33 | 1740 | ||
| 2026-05-29 | 424B3 | 424B3 | 0001493152-26-026446 | 333-291740 | 261046268 | 33 | 404629 | |||
| 2026-05-27 | 8-K | 8-K | 5.02,5.07,9.01 | 0001493152-26-025441 | 001-40739 | 261027254 | 34 | 293937 | 1 | 1 |
| 2026-05-27 | CORRESP | filename1.htm | 0001493152-26-025407 | 10755 | ||||||
| 2026-05-22 | S-3/A | S-3/A | 0001493152-26-025073 | 333-291740 | 261015055 | 33 | 622864 | 1 | 1 | |
| 2026-05-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001213900-26-055876 | 005-92822 | 26974106 | 34 | 11632 | |||
| 2026-05-13 | 10-Q | 10-Q | 0001493152-26-022719 | 001-40739 | 26973287 | 34 | 4809254 | 1 | 1 | |
| 2026-05-13 | 8-K | 8-K | 2.02,9.01 | 0001493152-26-022710 | 001-40739 | 26973203 | 34 | 685258 | 1 | 1 |
| 2026-04-22 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000921895-26-001059 | 005-92822 | 26884066 | 34 | 20659 | |||
| 2026-04-17 | ARS | ARS | 0001493152-26-017912 | 001-40739 | 26872532 | 34 | 2769114 | |||
| 2026-04-17 | DEFA14A | DEFA14A | 0001493152-26-017911 | 001-40739 | 26872511 | 34 | 1022286 | |||
| 2026-04-17 | DEF 14A | DEF 14A | 0001493152-26-017909 | 001-40739 | 26872492 | 34 | 2503330 | 1 | 1 | |
| 2026-04-07 | PRE 14A | PRE 14A | 0001493152-26-015348 | 001-40739 | 26842372 | 34 | 2503132 | 1 | 1 | |
| 2026-03-26 | 10-K | 10-K | 0001493152-26-012992 | 001-40739 | 26799477 | 34 | 9237169 | 1 | 1 | |
| 2026-03-26 | 8-K | 8-K | 2.02,9.01 | 0001493152-26-012991 | 001-40739 | 26799450 | 34 | 323266 | 1 | 1 |
| 2026-03-17 | 4 | 4 | 0001493152-26-010630 | 5344 | ||||||
| 2026-02-25 | 8-K | 8-K | 5.02 | 0001493152-26-008037 | 001-40739 | 26678478 | 34 | 250424 | 1 | 1 |
| 2026-02-23 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001493152-26-007792 | 005-92822 | 26667090 | 34 | 8655 | |||
| 2026-02-18 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-26-001308 | 005-92822 | 26649458 | 34 | 10563 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-26-001248 | 005-92822 | 26645096 | 34 | 10492 | |||
| 2026-02-09 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-26-000261 | 005-92822 | 26612701 | 34 | 21708 | |||
| 2026-02-03 | 8-K | 8-K | 4.01,9.01 | 0001493152-26-004905 | 001-40739 | 26592829 | 34 | 262942 | 1 | 1 |
| 2026-02-02 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001493152-26-004801 | 005-92822 | 26589373 | 34 | 8790 | |||
| 2026-01-29 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000354 | 333-292885 | 26580318 | 33 | 1739 | ||
| 2026-01-29 | 424B3 | 424B3 | 0001493152-26-004247 | 333-292885 | 26579265 | 33 | 257718 | |||
| 2026-01-27 | CORRESP | filename1.htm | 0001493152-26-003812 | 13763 | ||||||
| 2026-01-27 | UPLOAD | filename1.pdf | 0000000000-26-000945 | 333-292885 | 40048 | |||||
| 2026-01-27 | 8-K | 8-K | 8.01,9.01 | 0001493152-26-003715 | 001-40739 | 26562213 | 34 | 298471 | 1 | 1 |
| 2026-01-27 | 424B5 | 424B5 | 0001493152-26-003706 | 333-268383 | 26562079 | 33 | 16548 | |||
| 2026-01-22 | S-3 | S-3 | 0001493152-26-003259 | 333-292885 | 26552393 | 33 | 532977 | 1 | 1 | |
| 2026-01-08 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001493152-26-000967 | 005-92822 | 26519611 | 34 | 14399 | |||
| 2026-01-07 | D | xslFormDX01/primary_doc.xml | 06b | 0001493152-26-000797 | 021-569228 | 26515742 | 33 | 14923 | ||
| 2026-01-06 | 4 | xslF345X05/ownership.xml | 0001493152-26-000698 | 5700 | ||||||
| 2026-01-06 | 4 | xslF345X05/ownership.xml | 0001493152-26-000703 | 5667 | ||||||
| 2026-01-06 | 4 | 4 | 0001493152-26-000699 | 5567 | ||||||
| 2026-01-06 | 4 | xslF345X05/ownership.xml | 0001493152-26-000704 | 5564 | ||||||
| 2026-01-06 | 4 | 4 | 0001493152-26-000697 | 5590 | ||||||
| 2026-01-06 | 4 | xslF345X05/ownership.xml | 0001493152-26-000702 | 5507 | ||||||
| 2026-01-06 | 4 | 4 | 0001493152-26-000696 | 5493 | ||||||
| 2026-01-06 | 4 | 4 | 0001493152-26-000701 | 5494 | ||||||
| 2026-01-06 | 4 | xslF345X05/ownership.xml | 0001493152-26-000695 | 5555 | ||||||
| 2026-01-06 | 4 | 4 | 0001493152-26-000700 | 5555 | ||||||
| 2026-01-06 | 4 | 4 | 0001493152-26-000694 | 5581 | ||||||
| 2026-01-02 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-26-000486 | 005-92822 | 26503011 | 34 | 21431 | |||
| 2025-12-30 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-25-003402 | 005-92822 | 251614489 | 34 | 31880 | |||
| 2025-12-29 | 4 | xslF345X05/ownership.xml | 0001493152-25-029470 | 16414 | ||||||
| 2025-12-29 | 4 | xslF345X05/ownership.xml | 0001493152-25-029468 | 27049 | ||||||
| 2025-12-29 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001493152-25-029364 | 001-40739 | 251609173 | 34 | 1330452 | 1 | 1 |
| 2025-11-24 | S-3 | S-3 | 0001493152-25-024720 | 333-291740 | 251509361 | 33 | 1812647 | 1 | 1 | |
| 2025-11-18 | 8-K | 8-K | 1.02 | 0001493152-25-023942 | 001-40739 | 251492322 | 34 | 255296 | 1 | 1 |
| 2025-11-14 | 10-Q | 10-Q | 0001493152-25-023474 | 001-40739 | 251486224 | 34 | 4793045 | 1 | 1 | |
| 2025-11-14 | 8-K | 8-K | 2.02,7.01,9.01 | 0001493152-25-023419 | 001-40739 | 251485851 | 34 | 328464 | 1 | 1 |
| 2025-11-07 | 8-K | 8-K | 8.01,9.01 | 0001493152-25-021255 | 001-40739 | 251462618 | 34 | 299773 | 1 | 1 |
| 2025-11-07 | 424B5 | 424B5 | 0001493152-25-021254 | 333-268383 | 251462589 | 33 | 13883 | |||
| 2025-09-17 | 8-K | 8-K | 8.01 | 0001493152-25-013815 | 001-40739 | 251318741 | 34 | 271374 | 1 | 1 |
| 2025-09-10 | 8-K | 8-K | 8.01 | 0001493152-25-012952 | 001-40739 | 251304702 | 34 | 254138 | 1 | 1 |
| 2025-08-25 | 8-K | 8-K | 8.01 | 0001641172-25-025405 | 001-40739 | 251251719 | 34 | 252394 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-003583 | 005-92822 | 251222137 | 34 | 10349 | |||
| 2025-08-13 | 10-Q | 10-Q | 0001641172-25-023572 | 001-40739 | 251212689 | 34 | 4429366 | 1 | 1 | |
| 2025-08-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0001641172-25-023570 | 001-40739 | 251212663 | 34 | 314291 | 1 | 1 |
| 2025-07-30 | 8-K | 8-K | 3.03,5.03,9.01 | 0001641172-25-021501 | 001-40739 | 251164194 | 34 | 283216 | 1 | 1 |
| 2025-07-16 | 8-K | 8-K | 5.07 | 0001641172-25-019760 | 001-40739 | 251125812 | 34 | 273333 | 1 | 1 |
| 2025-07-07 | 8-K | 8-K | 3.01 | 0001641172-25-018042 | 001-40739 | 251108956 | 34 | 258536 | 1 | 1 |
| 2025-06-05 | 8-K | 8-K | 4.01,9.01 | 0001641172-25-013823 | 001-40739 | 251027559 | 34 | 260054 | 1 | 1 |
| 2025-06-02 | ARS | ARS | 0001641172-25-013239 | 001-40739 | 251015016 | 34 | 2091060 | |||
| 2025-06-02 | DEFA14A | DEFA14A | 0001641172-25-013238 | 001-40739 | 251014980 | 34 | 4926959 | |||
| 2025-06-02 | DEF 14A | DEF 14A | 0001641172-25-013237 | 001-40739 | 251014938 | 34 | 1293716 | |||
| 2025-05-23 | PRE 14A | PRE 14A | 0001641172-25-012257 | 001-40739 | 25982090 | 34 | 1671162 | |||
| 2025-05-21 | 8-K | 8-K | 7.01,8.01 | 0001641172-25-011873 | 001-40739 | 25971019 | 34 | 260745 | 1 | 1 |
| 2025-05-16 | 8-K | 8-K | 3.01 | 0001641172-25-011286 | 001-40739 | 25960640 | 34 | 271144 | 1 | 1 |
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-002251 | 005-92822 | 25951935 | 34 | 10501 | |||
| 2025-05-14 | 8-K | 8-K | 2.02,7.01,9.01 | 0001641172-25-010112 | 001-40739 | 25942979 | 34 | 311928 | 1 | 1 |
| 2025-05-14 | 10-Q | 10-Q | 0001641172-25-010111 | 001-40739 | 25942975 | 34 | 4585300 | 1 | 1 | |
| 2025-05-09 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-041511 | 005-92822 | 25930255 | 34 | 11186 | |||
| 2025-04-23 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001212 | 333-286547 | 25863377 | 33 | 1739 | ||
| 2025-04-23 | 424B3 | form424b3.htm | 0001641172-25-005881 | 333-286547 | 25862399 | 33 | 154470 | |||
| 2025-04-21 | CORRESP | filename1.htm | 0001641172-25-005582 | 13227 | ||||||
| 2025-04-21 | UPLOAD | filename1.pdf | 0000000000-25-004185 | 333-286547 | 40086 | |||||
| 2025-04-15 | S-3 | FORM S-3 | 0001654954-25-004304 | 333-286547 | 25839723 | 33 | 292320 | |||
| 2025-04-15 | 8-K | FORM 8-K | 7.01,8.01,9.01 | 0001654954-25-004265 | 001-40739 | 25837692 | 34 | 216655 | 1 | 1 |
| 2025-04-07 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001641172-25-003085 | 005-92822 | 25819982 | 34 | 10932 | |||
| 2025-04-03 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001641172-25-002621 | 005-92822 | 25811276 | 34 | 10562 | |||
| 2025-03-28 | 8-K | FORM 8-K | 1.01,3.02,3.03,9.01 | 0001654954-25-003552 | 001-40739 | 25787419 | 34 | 539938 | 1 | 1 |
| 2025-03-27 | 8-K | FORM 8-K | 7.01,8.01,9.01 | 0001654954-25-003372 | 001-40739 | 25775385 | 34 | 224984 | 1 | 1 |
| 2025-03-25 | 8-K | FORM 8-K | 3.01 | 0001654954-25-003305 | 001-40739 | 25769442 | 34 | 173061 | 1 | 1 |
| 2025-03-17 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001654954-25-002886 | 001-40739 | 25744698 | 34 | 241518 | 1 | 1 |
| 2025-03-17 | 10-K | FORM 10-K | 0001654954-25-002885 | 001-40739 | 25744617 | 34 | 6693166 | 1 | 1 | |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-001304 | 005-92822 | 25631368 | 34 | 10508 | |||
| 2025-02-13 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001493152-25-006502 | 005-92822 | 25622030 | 34 | 13459 | |||
| 2025-02-05 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000328 | 333-284603 | 25595224 | 33 | 1746 | ||
| 2025-02-05 | 424B3 | 424B3 | 0001654954-25-001172 | 333-284603 | 25594636 | 33 | 199936 | |||
| 2025-02-04 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001493152-25-004861 | 021-536542 | 25588576 | 33 | 14580 | ||
| 2025-02-03 | CORRESP | filename1.htm | 0001654954-25-001100 | 8195 | ||||||
| 2025-02-03 | UPLOAD | filename1.pdf | 0000000000-25-001141 | 333-284603 | 40114 | |||||
| 2025-01-30 | S-3 | S-3 | 0001654954-25-000940 | 333-284603 | 25573794 | 33 | 324148 | |||
| 2025-01-28 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-25-007608 | 005-92822 | 25565848 | 34 | 15738 | |||
| 2025-01-28 | D | xslFormDX01/primary_doc.xml | 06b | 0001493152-25-004008 | 021-536542 | 25565308 | 33 | 14485 | ||
| 2025-01-23 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001493152-25-003484 | 005-92822 | 25551467 | 34 | 13449 | |||
| 2025-01-23 | 4 | FORM 4 | 0001654954-25-000693 | 7631 | ||||||
| 2025-01-23 | 4 | PRIMARY DOCUMENT | 0001654954-25-000692 | 7621 | ||||||
| 2025-01-23 | 4 | PRIMARY DOCUMENT | 0001654954-25-000691 | 12159 | ||||||
| 2025-01-23 | 4 | PRIMARY DOCUMENT | 0001654954-25-000690 | 10524 | ||||||
| 2025-01-23 | 8-K | FORM 8-K | 1.01,3.02,8.01,9.01 | 0001654954-25-000681 | 001-40739 | 25550341 | 34 | 1046034 | 1 | 1 |
| 2025-01-21 | 8-K | FORM 8-K | 1.01,7.01,9.01 | 0001654954-25-000570 | 001-40739 | 25540488 | 34 | 466274 | 1 | 1 |
| 2025-01-14 | 4 | FORM 4 | 0001654954-25-000414 | 5172 | ||||||
| 2025-01-14 | 4 | PRIMARY DOCUMENT | 0001654954-25-000413 | 5373 | ||||||
| 2025-01-14 | 4 | FORM 4 | 0001654954-25-000412 | 5232 | ||||||
| 2025-01-14 | 4 | FORM 4 | 0001654954-25-000411 | 5269 | ||||||
| 2025-01-14 | 4 | PRIMARY DOCUMENT | 0001654954-25-000410 | 5472 | ||||||
| 2025-01-14 | 4 | PRIMARY DOCUMENT | 0001654954-25-000409 | 5405 | ||||||
| 2025-01-14 | 4 | FORM 4 | 0001654954-25-000400 | 5340 | ||||||
| 2025-01-14 | 4 | FORM 4 | 0001654954-25-000399 | 5188 | ||||||
| 2025-01-14 | 4 | FORM 4 | 0001654954-25-000398 | 5357 | ||||||
| 2025-01-14 | 4 | PRIMARY DOCUMENT | 0001654954-25-000397 | 5232 | ||||||
| 2025-01-14 | 4 | FORM 4 | 0001654954-25-000396 | 5240 | ||||||
| 2024-11-14 | SC 13G/A | armistice-drma093024a1.htm | 0001172661-24-005311 | 005-92822 | 241464140 | 34 | 90568 | |||
| 2024-11-14 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001654954-24-014289 | 001-40739 | 241456023 | 34 | 257424 | 1 | 1 |
| 2024-11-13 | 10-Q | FORM 10-Q | 0001654954-24-014274 | 001-40739 | 241454504 | 34 | 3621633 | 1 | 1 | |
| 2024-09-27 | D | xslFormDX01/primary_doc.xml | 06b | 0001493152-24-038572 | 021-525299 | 241335786 | 33 | 14408 | ||
| 2024-09-24 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-09-24 16:00:00 | 9999999995-24-002950 | 333-282223 | 241321194 | 33 | 1747 | ||
| 2024-09-24 | 424B3 | 424B3 | 0001654954-24-012245 | 333-282223 | 241320394 | 33 | 176060 | |||
| 2024-09-23 | UPLOAD | filename1.pdf | 0000000000-24-010780 | 333-282223 | 40048 | |||||
| 2024-09-23 | CORRESP | filename1.htm | 0001654954-24-012156 | 7567 | ||||||
| 2024-09-19 | S-3 | FORM S-3 | 0001654954-24-012106 | 333-282223 | 241310921 | 33 | 301937 | |||
| 2024-09-17 | 8-K | FORM 8-K | 1.01,3.02,8.01,9.01 | 0001654954-24-012031 | 001-40739 | 241305438 | 34 | 1058209 | 1 | 1 |
| 2024-08-07 | S-8 | FORM S-8 | 0001654954-24-010111 | 333-281338 | 241184597 | 33 | 109307 | |||
| 2024-08-07 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001654954-24-010104 | 001-40739 | 241183634 | 34 | 275141 | 1 | 1 |
| 2024-08-07 | 10-Q | FORM 10-Q | 0001654954-24-010103 | 001-40739 | 241183603 | 34 | 3459322 | 1 | 1 | |
| 2024-08-02 | 8-K | FORM 8-K | 8.01,9.01 | 0001654954-24-009903 | 001-40739 | 241172204 | 34 | 201567 | 1 | 1 |
| 2024-08-02 | 424B5 | 424B5 | 0001654954-24-009900 | 333-268383 | 241172184 | 33 | 12952 | |||
| 2024-07-15 | 424B3 | 424B3 | 0001654954-24-008937 | 333-280682 | 241117341 | 33 | 162262 | |||
| 2024-07-12 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-07-12 16:15:00 | 9999999995-24-002156 | 333-280682 | 241115759 | 33 | 1747 | ||
| 2024-07-10 | CORRESP | filename1.htm | 0001654954-24-008789 | 8577 | ||||||
| 2024-07-08 | UPLOAD | filename1.pdf | 0000000000-24-007677 | 333-280682 | 40062 | |||||
| 2024-07-03 | S-3 | FORM S-3 | 0001654954-24-008609 | 333-280682 | 241100093 | 33 | 291509 | |||
| 2024-06-07 | 8-K | FORM 8-K | 1.01,9.01 | 0001654954-24-007532 | 001-40739 | 241030619 | 34 | 475473 | 1 | 1 |
| 2024-06-07 | 424B5 | FORM 424B5 | 0001654954-24-007531 | 333-268383 | 241030601 | 33 | 470559 | |||
| 2024-06-05 | 8-K | FORM 8-K | 8.01 | 0001654954-24-007369 | 001-40739 | 241020927 | 34 | 169239 | 1 | 1 |
| 2024-05-24 | 8-K | FORM 8-K | 3.01 | 0001654954-24-006912 | 001-40739 | 24984281 | 34 | 169084 | 1 | 1 |
| 2024-05-17 | 8-K | FORM 8-K | 1.01,3.02,3.03,9.01 | 0001654954-24-006608 | 001-40739 | 24959710 | 34 | 537638 | 1 | 1 |
| 2024-05-15 | 10-Q | FORM 10-Q | 0001654954-24-006398 | 001-40739 | 24950516 | 34 | 3038678 | 1 | 1 | |
| 2024-05-15 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001654954-24-006396 | 001-40739 | 24950481 | 34 | 223110 | 1 | 1 |
| 2024-05-15 | 8-K | FORM 8-K | 3.01,8.01 | 0001654954-24-006312 | 001-40739 | 24947473 | 34 | 177690 | 1 | 1 |
| 2024-05-14 | 8-K | FORM 8-K | 3.03,5.03,9.01 | 0001654954-24-006133 | 001-40739 | 24941721 | 34 | 201611 | 1 | 1 |
| 2024-05-07 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001654954-24-005715 | 001-40739 | 24923132 | 34 | 205668 | 1 | 1 |
| 2024-03-26 | ARS | ARS | 0001654954-24-003661 | 001-40739 | 24784235 | 34 | 113070791 | |||
| 2024-03-26 | DEFA14A | DEFA 14A | 0001654954-24-003658 | 001-40739 | 24784092 | 34 | 33850 | |||
| 2024-03-26 | DEF 14A | DEF 14A | 0001654954-24-003656 | 001-40739 | 24783957 | 34 | 756953 | |||
| 2024-03-21 | 10-K | FORM 10-K | 0001654954-24-003501 | 001-40739 | 24771310 | 34 | 5709778 | 1 | 1 | |
| 2024-03-21 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001654954-24-003500 | 001-40739 | 24771293 | 34 | 238083 | 1 | 1 |
| 2024-03-04 | PRE 14A | PRE 14A | 0001654954-24-002511 | 001-40739 | 24712163 | 34 | 747468 | |||
| 2024-02-14 | SC 13G | armistice-drma123123.htm | 0001172661-24-001340 | 005-92822 | 24636910 | 34 | 90520 | |||
| 2024-01-12 | 8-K | FORM 8-K | 5.07 | 0001654954-24-000520 | 001-40739 | 24532100 | 34 | 183299 | 1 | 1 |
| 2024-01-05 | 4 | FORM 4 | 0001654954-24-000300 | 4978 | ||||||
| 2024-01-05 | 4 | FORM 4 | 0001654954-24-000299 | 5362 | ||||||
| 2024-01-05 | 4 | FORM 4 | 0001654954-24-000298 | 5098 | ||||||
| 2024-01-05 | 4 | FORM 4 | 0001654954-24-000297 | 4998 | ||||||
| 2024-01-05 | 4 | FORM 4 | 0001654954-24-000296 | 4930 | ||||||
| 2024-01-05 | 4 | PRIMARY DOCUMENT | 0001654954-24-000295 | 5389 | ||||||
| 2024-01-05 | 4 | PRIMARY DOCUMENT | 0001654954-24-000294 | 5180 | ||||||
| 2024-01-05 | 4 | PRIMARY DOCUMENT | 0001654954-24-000293 | 5295 | ||||||
| 2024-01-05 | 4 | PRIMARY DOCUMENT | 0001654954-24-000292 | 5060 | ||||||
| 2024-01-05 | 4 | PRIMARY DOCUMENT | 0001654954-24-000291 | 5256 | ||||||
| 2024-01-05 | 4 | FORM 4 | 0001654954-24-000290 | 5274 | ||||||
| 2023-12-15 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-12-15 16:30:00 | 9999999995-23-003661 | 333-275931 | 231492134 | 33 | 1747 | ||
| 2023-12-15 | 424B3 | 424B3 | 0001654954-23-015637 | 333-275931 | 231491185 | 33 | 146216 | |||
| 2023-12-13 | CORRESP | filename1.htm | 0001654954-23-015475 | 8856 | ||||||
| 2023-12-13 | UPLOAD | filename1.pdf | 0000000000-23-013569 | 40280 | ||||||
| 2023-12-08 | DEF 14A | DEF 14A | 0001654954-23-015300 | 001-40739 | 231476437 | 34 | 215066 | |||
| 2023-12-07 | S-3 | FORM S-3 | 0001654954-23-015259 | 333-275931 | 231472405 | 33 | 270704 | |||
| 2023-11-29 | PRE 14A | PRE 14A | 0001654954-23-014925 | 001-40739 | 231453314 | 34 | 214540 | |||
| 2023-11-17 | 8-K | FORM 8-K | 1.01,3.02,3.03,9.01 | 0001654954-23-014542 | 001-40739 | 231418630 | 34 | 555354 | 1 | 1 |
| 2023-11-16 | 8-K | FORM 8-K | 3.01 | 0001654954-23-014446 | 001-40739 | 231411868 | 34 | 172028 | 1 | 1 |
| 2023-11-09 | 10-Q | FORM 10-Q | 0001654954-23-014016 | 001-40739 | 231392422 | 34 | 3173591 | 1 | 1 | |
| 2023-11-09 | 8-K | FORM 8-K | 2.02,4.01,7.01,9.01 | 0001654954-23-014015 | 001-40739 | 231392405 | 34 | 293786 | 1 | 1 |
| 2023-09-14 | S-8 | FORM S-8 | 0001654954-23-011891 | 333-274513 | 231255490 | 33 | 104182 | |||
| 2023-08-10 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001654954-23-010489 | 001-40739 | 231159759 | 34 | 238202 | 1 | 1 |
| 2023-08-10 | 10-Q | FORM 10-Q | 0001654954-23-010487 | 001-40739 | 231159710 | 34 | 3144447 | 1 | 1 | |
| 2023-08-03 | 8-K | FORM 8-K | 4.01,5.02,5.07,9.01 | 0001654954-23-010092 | 001-40739 | 231140613 | 34 | 199113 | 1 | 1 |
| 2023-07-27 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2023-07-27 16:30:00 | 9999999995-23-002202 | 333-273170 | 231120027 | 33 | 1698 | ||
| 2023-07-27 | 424B4 | 424B4 | 0001654954-23-009750 | 333-273170 | 231119200 | 33 | 175784 | |||
| 2023-07-25 | CORRESP | filename1.htm | 0001654954-23-009659 | 6114 | ||||||
| 2023-07-14 | UPLOAD | filename1.pdf | 0000000000-23-007558 | 40229 | ||||||
| 2023-07-12 | DEFA14A | DEFA14A | 0001654954-23-009043 | 001-40739 | 231083334 | 34 | 19868 | |||
| 2023-07-07 | S-1 | FORM S-1 | 0001654954-23-008945 | 333-273170 | 231077017 | 33 | 343651 | |||
| 2023-06-23 | ARS | ARS | 0001654954-23-008355 | 001-40739 | 231038113 | 34 | 128271027 | |||
| 2023-06-23 | DEFA14A | DEFA14A | 0001654954-23-008354 | 001-40739 | 231038098 | 34 | 27978 | |||
| 2023-06-23 | DEF 14A | DEF 14A | 0001654954-23-008352 | 001-40739 | 231037938 | 34 | 586074 | |||
| 2023-06-12 | D | xslFormDX01/primary_doc.xml | 06b | 0001654954-23-007925 | 021-483997 | 231009440 | 33 | 14693 | ||
| 2023-06-01 | SC 13G | SCHEDULE 13G | 0001213900-23-045130 | 005-92822 | 23985733 | 34 | 96686 | |||
| 2023-05-25 | 424B5 | 424B5 | 0001654954-23-007244 | 333-268383 | 23962117 | 33 | 447592 | |||
| 2023-05-24 | 8-K | FORM 8-K | 1.01,3.02,7.01,9.01 | 0001654954-23-007177 | 001-40739 | 23955070 | 34 | 882330 | 1 | 1 |
| 2023-05-11 | 10-Q | FORM 10-Q | 0001654954-23-006208 | 001-40739 | 23910988 | 34 | 2664263 | 1 | 1 | |
| 2023-05-11 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001654954-23-006209 | 001-40739 | 23910984 | 34 | 292144 | 1 | 1 |
| 2023-03-31 | SC 13D/A | SC 13D/A | 0001654954-23-004104 | 005-92822 | 23787584 | 34 | 48397 | |||
| 2023-03-30 | SC 13D/A | FORM SC 13D/A | 0001654954-23-003923 | 005-92822 | 23780674 | 34 | 48642 | |||
| 2023-03-28 | 10-K/A | FORM 10-K/A | 0001654954-23-003730 | 001-40739 | 23770786 | 34 | 324861 | 1 | 1 | |
| 2023-03-28 | 8-K | FORM 8-K | 8.01 | 0001654954-23-003722 | 001-40739 | 23769534 | 34 | 165023 | 1 | 1 |
| 2023-03-21 | 424B3 | 424B3 | 0001654954-23-003198 | 333-264668 | 23747313 | 33 | 18270 | |||
| 2023-03-20 | 8-K | FORM 8-K | 1.01,7.01,9.01 | 0001654954-23-003181 | 001-40739 | 23746752 | 34 | 214759 | 1 | 1 |
| 2023-03-20 | 424B4 | FORM 424B4 | 0001654954-23-003148 | 333-270195 | 23745036 | 33 | 267564 | |||
| 2023-03-16 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2023-03-16 13:00:00 | 9999999995-23-000594 | 333-270195 | 23740590 | 33 | 1697 | ||
| 2023-03-16 | CORRESP | filename1.htm | 0001654954-23-002983 | 22950 | ||||||
| 2023-03-16 | CORRESP | filename1.htm | 0001654954-23-002981 | 11761 | ||||||
| 2023-03-16 | S-1/A | FORM S-1/A | 0001654954-23-002967 | 333-270195 | 23737396 | 33 | 748609 | |||
| 2023-03-15 | S-1/A | FORM S-1/A | 0001654954-23-002876 | 333-270195 | 23732885 | 33 | 421397 | |||
| 2023-03-14 | CORRESP | filename1.htm | 0001654954-23-002834 | 10557 | ||||||
| 2023-03-14 | CORRESP | filename1.htm | 0001654954-23-002832 | 17971 | ||||||
| 2023-03-13 | S-1/A | FORM S-1/A | 0001654954-23-002742 | 333-270195 | 23728120 | 33 | 1035775 | |||
| 2023-03-13 | CORRESP | filename1.htm | 0001654954-23-002716 | 5414 | ||||||
| 2023-03-13 | CORRESP | filename1.htm | 0001654954-23-002715 | 5887 | ||||||
| 2023-03-13 | 8-K | FORM 8-K | 3.03,5.03,9.01 | 0001654954-23-002711 | 001-40739 | 23726661 | 34 | 192555 | 1 | 1 |
| 2023-03-06 | UPLOAD | filename1.pdf | 0000000000-23-002215 | 40284 | ||||||
| 2023-03-01 | S-1 | FORM S-1 | 0001654954-23-002273 | 333-270195 | 23694765 | 33 | 440782 | |||
| 2023-02-21 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001654954-23-001927 | 001-40739 | 23648191 | 34 | 315868 | 1 | 1 |
| 2023-02-21 | 10-K | FORM 10-K | 0001654954-23-001926 | 001-40739 | 23648187 | 34 | 6644443 | 1 | 1 | |
| 2023-02-08 | 8-K | FORM 8-K | 5.07 | 0001654954-23-001476 | 001-40739 | 23599074 | 34 | 172644 | 1 | 1 |
| 2023-01-18 | SC 13D/A | SC 13D/A | 0001654954-23-000567 | 005-92822 | 23535034 | 34 | 43126 | |||
| 2023-01-13 | DEF 14A | DEF 14A | 0001654954-23-000377 | 001-40739 | 23527303 | 34 | 250435 | |||
| 2023-01-05 | 4 | FORM 4 | 0001654954-23-000148 | 5154 | ||||||
| 2023-01-05 | 4 | PRIMARY DOCUMENT | 0001654954-23-000147 | 5080 | ||||||
| 2023-01-05 | 4 | PRIMARY DOCUMENT | 0001654954-23-000146 | 5216 | ||||||
| 2023-01-03 | PRE 14A | PRE 14A | 0001654954-23-000060 | 001-40739 | 23502280 | 34 | 198303 | |||
| 2022-12-29 | RW | RW | 0001654954-22-017049 | 333-262536 | 221499009 | NE | 9440 | |||
| 2022-12-15 | 8-K | FORM 8-K | 3.01,8.01 | 0001654954-22-016569 | 001-40739 | 221464834 | 34 | 181266 | 1 | 1 |
| 2022-12-05 | 8-K | FORM 8-K | 7.01,8.01,9.01 | 0001654954-22-016099 | 001-40739 | 221443862 | 34 | 191499 | 1 | 1 |
| 2022-11-25 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-11-25 17:00:00 | 9999999995-22-003396 | 333-268383 | 221421033 | 33 | 1698 | ||
| 2022-11-22 | CORRESP | filename1.htm | 0001654954-22-015659 | 8801 | ||||||
| 2022-11-22 | UPLOAD | filename1.pdf | 0000000000-22-012672 | 40176 | ||||||
| 2022-11-15 | S-3 | FORM S-3 | 0001654954-22-015367 | 333-268383 | 221391204 | 33 | 1258521 | |||
| 2022-11-10 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001654954-22-015036 | 001-40739 | 221378686 | 34 | 294452 | 1 | 1 |
| 2022-11-10 | 10-Q | FORM 10-Q | 0001654954-22-015035 | 001-40739 | 221378662 | 34 | 4889804 | 1 | 1 | |
| 2022-10-07 | 4 | PRIMARY DOCUMENT | 0001654954-22-013530 | 4288 | ||||||
| 2022-10-07 | 4 | PRIMARY DOCUMENT | 0001654954-22-013529 | 4346 | ||||||
| 2022-10-07 | 4 | PRIMARY DOCUMENT | 0001654954-22-013528 | 7111 | ||||||
| 2022-10-07 | 4 | PRIMARY DOCUMENT | 0001654954-22-013527 | 4454 | ||||||
| 2022-10-07 | 4 | PRIMARY DOCUMENT | 0001654954-22-013526 | 5063 | ||||||
| 2022-10-07 | 4 | PRIMARY DOCUMENT | 0001654954-22-013525 | 4333 | ||||||
| 2022-09-23 | 8-K | FORM 8-K | 5.03,9.01 | 0001654954-22-012918 | 001-40739 | 221262378 | 34 | 172684 | 1 | 1 |
| 2022-08-26 | S-8 | FORM S-8 | 0001654954-22-011891 | 333-267115 | 221206016 | 33 | 142854 | |||
| 2022-08-15 | 10-Q | FORM 10-Q | 0001654954-22-011375 | 001-40739 | 221165956 | 34 | 4531051 | 1 | 1 | |
| 2022-08-15 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001654954-22-011373 | 001-40739 | 221165906 | 34 | 272794 | 1 | 1 |
| 2022-07-11 | 8-K | FORM 8-K | 5.03,5.07,9.01 | 0001654954-22-009535 | 001-40739 | 221077540 | 34 | 190191 | 1 | 1 |
| 2022-07-08 | 4 | FORM 4 | 0001654954-22-009457 | 4304 | ||||||
| 2022-07-08 | 4 | FORM 4 | 0001654954-22-009456 | 4363 | ||||||
| 2022-07-08 | 4 | PRIMARY DOCUMENT | 0001654954-22-009455 | 6410 | ||||||
| 2022-07-08 | 4 | PRIMARY DOCUMENT | 0001654954-22-009454 | 5064 | ||||||
| 2022-07-08 | 4 | PRIMARY DOCUMENT | 0001654954-22-009453 | 4334 | ||||||
| 2022-07-08 | 4 | PRIMARY DOCUMENT | 0001654954-22-009452 | 4455 | ||||||
| 2022-07-07 | 4 | PRIMARY DOCUMENT | 0001654954-22-009392 | 5194 | ||||||
| 2022-06-24 | 424B3 | 424B3 | 0001654954-22-008771 | 333-264668 | 221040884 | 33 | 56607 | |||
| 2022-06-24 | 8-K | FORM 8-K | 5.02 | 0001654954-22-008770 | 001-40739 | 221040824 | 34 | 163929 | 1 | 1 |
| 2022-06-22 | 8-K | FORM 8-K | 3.01 | 0001654954-22-008628 | 001-40739 | 221032794 | 34 | 165554 | 1 | 1 |
| 2022-06-01 | DEFA14A | DEFA14A | 0001654954-22-007815 | 001-40739 | 22988105 | 34 | 46685 | |||
| 2022-06-01 | DEF 14A | DEF 14A | 0001654954-22-007809 | 001-40739 | 22987613 | 34 | 557971 | |||
| 2022-05-20 | PRE 14A | PRE 14A | 0001654954-22-007310 | 001-40739 | 22947571 | 34 | 506637 | |||
| 2022-05-19 | 424B3 | 424B3 | 0001654954-22-007212 | 333-264668 | 22942824 | 33 | 571784 | |||
| 2022-05-17 | 8-K | FORM 8-K | 8.01 | 0001654954-22-007063 | 001-40739 | 22934508 | 34 | 163033 | 1 | 1 |
| 2022-05-16 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001654954-22-006969 | 001-40739 | 22928968 | 34 | 230251 | 1 | 1 |
| 2022-05-16 | 10-Q | FORM 10-Q | 0001654954-22-006966 | 001-40739 | 22928821 | 34 | 3890927 | 1 | 1 | |
| 2022-05-13 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2022-05-13 16:00:00 | 9999999995-22-001473 | 333-264668 | 22925142 | 33 | 1697 | ||
| 2022-05-13 | 424B4 | FORM 424B4 | 0001654954-22-006773 | 333-264668 | 22923863 | 33 | 2239466 | |||
| 2022-05-11 | CORRESP | filename1.htm | 0001654954-22-006454 | 12770 | ||||||
| 2022-05-10 | UPLOAD | filename1.pdf | 0000000000-22-005080 | 40175 | ||||||
| 2022-05-05 | SC 13D/A | formsc13da.htm | 0001493152-22-012278 | 005-92822 | 22897449 | 34 | 77033 | |||
| 2022-05-04 | S-1 | FORM S-1 | 0001654954-22-005986 | 333-264668 | 22891616 | 33 | 6829865 | 1 | 1 | |
| 2022-04-25 | 8-K | FORM 8-K | 1.01,3.02,8.01,9.01 | 0001654954-22-005375 | 001-40739 | 22850282 | 34 | 934297 | 1 | 1 |
| 2022-04-08 | 4 | xslF345X03/dermata_fm4apr72022.xml | 0000905718-22-000572 | 4678 | ||||||
| 2022-04-08 | 4 | xslF345X03/dermata_fm4apr72022.xml | 0000905718-22-000570 | 4663 | ||||||
| 2022-04-08 | 4 | xslF345X03/dermata_fm4apr72022.xml | 0000905718-22-000568 | 5407 | ||||||
| 2022-04-08 | 4 | xslF345X03/dermata_fm4apr72022.xml | 0000905718-22-000566 | 4659 | ||||||
| 2022-04-08 | 4 | xslF345X03/dermata_fm4apr72022.xml | 0000905718-22-000564 | 4749 | ||||||
| 2022-04-08 | 4 | xslF345X03/dermata_fm4apr72022.xml | 0000905718-22-000562 | 6619 | ||||||
| 2022-03-28 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001654954-22-003871 | 001-40739 | 22773295 | 34 | 317947 | 1 | 1 |
| 2022-03-28 | 10-K | FORM 10-K | 0001654954-22-003869 | 001-40739 | 22773291 | 34 | 6676103 | 1 | 1 | |
| 2022-03-02 | 8-K | FORM 8-K | 8.01 | 0001654954-22-002423 | 001-40739 | 22705216 | 34 | 162780 | 1 | 1 |
| 2022-02-07 | S-1/A | FORM S-1/A | 0001654954-22-001233 | 333-262536 | 22598470 | 33 | 342118 | |||
| 2022-02-04 | FWP | FWP | 0001654954-22-001137 | 333-262536 | 22594280 | 34 | 18229200 | |||
| 2022-02-04 | 8-K | FORM 8-K | 8.01 | 0001654954-22-001134 | 001-40739 | 22594085 | 34 | 166168 | 1 | 1 |
| 2022-02-04 | S-1 | FORM S-1 | 0001654954-22-001132 | 333-262536 | 22594069 | 33 | 9467271 | 1 | 1 | |
| 2022-01-14 | 4 | xslF345X03/dermata_fm4jan122022.xml | 0000905718-22-000113 | 5261 | ||||||
| 2022-01-14 | 3 | xslF345X02/dermata_fm3jan122022.xml | 0000905718-22-000111 | 8965 | ||||||
| 2022-01-13 | 8-K | CURRENT REPORT | 5.02,7.01,9.01 | 0001654954-22-000428 | 001-40739 | 22527956 | 34 | 188963 | 1 | 1 |
| 2022-01-11 | DRS | filename1.htm | 0001654954-22-000352 | 377-05918 | 22522769 | 33 | 3186812 | |||
| 2022-01-05 | 4 | xslF345X03/dermata_fm4jan32022.xml | 0000905718-22-000054 | 5163 | ||||||
| 2022-01-05 | 4 | xslF345X03/dermata_fm4jan32022.xml | 0000905718-22-000052 | 5367 | ||||||
| 2022-01-05 | 4 | xslF345X03/dermata_fm4jan32022.xml | 0000905718-22-000050 | 5380 | ||||||
| 2022-01-05 | 4 | xslF345X03/dermata_fm4jan32022.xml | 0000905718-22-000048 | 5307 | ||||||
| 2022-01-05 | 4 | xslF345X03/dermata_fm4jan32022.xml | 0000905718-22-000046 | 5208 | ||||||
| 2022-01-05 | 4 | xslF345X03/dermata_fm4jan32022.xml | 0000905718-22-000044 | 5231 | ||||||
| 2022-01-05 | 4 | xslF345X03/dermata_fm4jan32022.xml | 0000905718-22-000042 | 5211 | ||||||
| 2022-01-05 | 4 | xslF345X03/dermata_fm4jan32022.xml | 0000905718-22-000040 | 5196 | ||||||
| 2022-01-05 | 4 | xslF345X03/dermata_fm4jan32022.xml | 0000905718-22-000038 | 5445 | ||||||
| 2022-01-05 | 4 | xslF345X03/dermata_fm4jan32022.xml | 0000905718-22-000036 | 11874 | ||||||
| 2021-12-10 | S-8 | FORM S-8 | 0001654954-21-013056 | 333-261606 | 211486353 | 33 | 138974 | |||
| 2021-12-10 | 8-K | FORM 8-K | 5.02,9.01 | 0001654954-21-013038 | 001-40739 | 211484747 | 34 | 13174882 | 1 | 1 |
| 2021-11-26 | 4 | xslF345X03/dermata_fm4nov232021.xml | 0000905718-21-001541 | 8800 | ||||||
| 2021-11-19 | 8-K | CURRENT REPORT | 7.01,8.01 | 0001654954-21-012446 | 001-40739 | 211426494 | 34 | 208743 | 1 | 1 |
| 2021-11-15 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001654954-21-012224 | 001-40739 | 211411012 | 34 | 237861 | 1 | 1 |
| 2021-11-15 | 10-Q | FORM 10-Q | 0001654954-21-012206 | 001-40739 | 211410469 | 34 | 4877155 | 1 | 1 | |
| 2021-09-27 | 10-Q | QUARTERLY REPORT | 0001654954-21-010437 | 001-40739 | 211281816 | 34 | 4255303 | 1 | 1 | |
| 2021-09-27 | 8-K | CURRENT REPORT | 2.02,7.01,9.01 | 0001654954-21-010436 | 001-40739 | 211281729 | 34 | 139592 | ||
| 2021-09-01 | 4 | xslF345X03/dermata_fm4sep121.xml | 0000905718-21-001165 | 5257 | ||||||
| 2021-09-01 | 3 | xslF345X02/dermata_fm3sep121.xml | 0000905718-21-001163 | 8964 | ||||||
| 2021-09-01 | 424B3 | 424B3 | 0001193125-21-263325 | 333-256997 | 211230839 | 33 | 83491 | |||
| 2021-09-01 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-21-263316 | 001-40739 | 211230554 | 34 | 71932 | ||
| 2021-08-27 | SC 13D | SC 13D | 0000905718-21-001151 | 005-92822 | 211219951 | 34 | 65546 | |||
| 2021-08-27 | SC 13D | SC 13D | 0000905718-21-001150 | 005-92822 | 211219904 | 34 | 70551 | |||
| 2021-08-17 | 4 | xslF345X03/dermata_fm4aug172021.xml | 0000905718-21-001114 | 5219 | ||||||
| 2021-08-17 | 4 | xslF345X03/dermata_fm4aug172021.xml | 0000905718-21-001112 | 29707 | ||||||
| 2021-08-17 | 4 | xslF345X03/dermata_fm4aug172021.xml | 0000905718-21-001110 | 34623 | ||||||
| 2021-08-17 | 4 | xslF345X03/dermata_fm4aug172021.xml | 0000905718-21-001108 | 26913 | ||||||
| 2021-08-17 | 4 | xslF345X03/dermata_fm4aug172021.xml | 0000905718-21-001106 | 5239 | ||||||
| 2021-08-17 | 4 | xslF345X03/dermata_fm4aug172021.xml | 0000905718-21-001104 | 6907 | ||||||
| 2021-08-17 | 4 | xslF345X03/dermata_fm4aug172021.xml | 0000905718-21-001102 | 5171 | ||||||
| 2021-08-17 | 4 | xslF345X03/dermata_fm4aug172021.xml | 0000905718-21-001100 | 5204 | ||||||
| 2021-08-17 | 4 | xslF345X03/dermata_fm4aug172021.xml | 0000905718-21-001098 | 7604 | ||||||
| 2021-08-17 | 4 | xslF345X03/dermata_fm4aug172021.xml | 0000905718-21-001096 | 8240 | ||||||
| 2021-08-17 | 4 | xslF345X03/dermata_fm4aug172021.xml | 0000905718-21-001094 | 48289 | ||||||
| 2021-08-16 | 424B4 | 424B4 | 0001193125-21-247886 | 333-256997 | 211179345 | 33 | 3189838 | |||
| 2021-08-13 | POS EX | POS EX | 0001193125-21-246076 | 333-256997 | 211172313 | 33 | 39910 | |||
| 2021-08-12 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-004513 | 271893 | ||||||
| 2021-08-12 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-08-12 17:00:00 | 9999999995-21-003176 | 333-256997 | 211169523 | 33 | 1698 | ||
| 2021-08-12 | 3 | xslF345X02/ownership.xml | 0000905718-21-001039 | 9873 | ||||||
| 2021-08-12 | 3 | xslF345X02/ownership.xml | 0000905718-21-001037 | 8905 | ||||||
| 2021-08-12 | 3 | xslF345X02/ownership.xml | 0000905718-21-001035 | 8887 | ||||||
| 2021-08-12 | 3 | xslF345X02/ownership.xml | 0000905718-21-001033 | 8859 | ||||||
| 2021-08-12 | 3 | xslF345X02/ownership.xml | 0000905718-21-001031 | 26136 | ||||||
| 2021-08-12 | 3 | xslF345X02/ownership.xml | 0000905718-21-001029 | 18839 | ||||||
| 2021-08-12 | 3 | xslF345X02/ownership.xml | 0000905718-21-001027 | 23437 | ||||||
| 2021-08-12 | 3 | xslF345X02/ownership.xml | 0000905718-21-001025 | 31118 | ||||||
| 2021-08-12 | 3 | xslF345X02/ownership.xml | 0000905718-21-001023 | 14083 | ||||||
| 2021-08-12 | 3 | xslF345X02/ownership.xml | 0000905718-21-001021 | 18557 | ||||||
| 2021-08-12 | 3 | xslF345X02/ownership.xml | 0000905718-21-001019 | 13510 | ||||||
| 2021-08-12 | S-1MEF | S-1MEF | 0001193125-21-244908 | 333-258772 | 211168820 | 33 | 51508 | |||
| 2021-08-12 | CERT | 8A_cert_DRMA.pdf | 0001354457-21-000928 | 001-40739 | 211166364 | 34 | 732495 | |||
| 2021-08-11 | 8-A12B | 8-A12B | 0001193125-21-243542 | 001-40739 | 211164579 | 34 | 15481 | |||
| 2021-08-10 | CORRESP | filename1.htm | 0001193125-21-241938 | 6551 | ||||||
| 2021-08-10 | CORRESP | filename1.htm | 0001193125-21-241929 | 7120 | ||||||
| 2021-08-06 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-004479 | 275765 | ||||||
| 2021-08-06 | S-1/A | S-1/A | 0001193125-21-238151 | 333-256997 | 211150355 | 33 | 3968543 | |||
| 2021-07-12 | FWP | FWP | 0001193125-21-213147 | 333-256997 | 211086034 | 34 | 11125022 | |||
| 2021-07-09 | CORRESP | filename1.htm | 0001193125-21-211508 | 13481 | ||||||
| 2021-07-09 | S-1/A | S-1/A | 0001193125-21-211505 | 333-256997 | 211082121 | 33 | 3127353 | |||
| 2021-07-08 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-004072 | 272466 | ||||||
| 2021-07-08 | UPLOAD | filename1.pdf | 0000000000-21-008446 | 43238 | ||||||
| 2021-07-02 | CORRESP | filename1.htm | 0001193125-21-207683 | 15578 | ||||||
| 2021-07-02 | S-1/A | S-1/A | 0001193125-21-207676 | 333-256997 | 211070694 | 33 | 3629171 | |||
| 2021-06-17 | UPLOAD | filename1.pdf | 0000000000-21-007506 | 46252 | ||||||
| 2021-06-10 | CORRESP | filename1.htm | 0001193125-21-187921 | 12489 | ||||||
| 2021-06-10 | S-1 | S-1 | 0001193125-21-187916 | 333-256997 | 211008919 | 33 | 4223491 | |||
| 2021-05-20 | UPLOAD | filename1.pdf | 0000000000-21-006390 | 43387 | ||||||
| 2021-05-07 | DRSLTR | filename1.htm | 0000950123-21-005604 | 33407 | ||||||
| 2021-05-07 | DRS/A | filename1.htm | 0000950123-21-005603 | 377-04573 | 21904185 | 33 | 2756768 | |||
| 2021-04-29 | UPLOAD | filename1.pdf | 0000000000-21-005494 | 58170 | ||||||
| 2021-04-02 | DRS | filename1.htm | 0000950123-21-004193 | 377-04573 | 21802223 | 33 | 2761837 |
One latest value per concept from companyfacts (221 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 4.93M | 2026-11-09 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| dei | EntityListingParValuePerShare | Entity Listing, Par Value Per Share | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| dei | EntityPublicFloat | Entity Public Float | USD | 3.10M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 677.25 | 2026-10-09 | S-3 | 2026-10-09 | 0001493152-26-046518 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 677.25 | 2026-10-09 | S-3 | 2026-10-09 | 0001493152-26-046518 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 7.78M | 2026-10-09 | S-3 | 2026-10-09 | 0001493152-26-046518 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-10-09 | S-3 | 2026-10-09 | 0001493152-26-046518 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-10-09 | S-3 | 2026-10-09 | 0001493152-26-046518 | |||
| us-gaap | AccountsPayableAndOtherAccruedLiabilities | Accounts Payable and Other Accrued Liabilities | USD | 100,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 1.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 210,235 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 10,993 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 84.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 42,179 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 25,112 | 2025-04-01 | 2025-06-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001493152-25-023474 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 3.09M | 2024-07-01 | 2024-09-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001493152-25-023474 |
| us-gaap | AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities | Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities | USD | -731,693 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001493152-25-023474 |
| us-gaap | AdvertisingExpense | Advertising Expense | USD | 300,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 1.34M | 2021-01-01 | 2021-03-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 10.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | Assets | Assets | USD | 6.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 6.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | Cash | Cash | USD | 8.19M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0001654954-22-006966 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 4.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 12.07M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0001654954-21-012206 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 5.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -4.28M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001654954-25-002885 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -2.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | CashFDICInsuredAmount | Cash, FDIC Insured Amount | USD | 250,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | CashUninsuredAmount | Cash, Uninsured Amount | USD | 250,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 4.91 | 2024-05-31 | 2024 | FY | 10-K | 2025-03-17 | 0001654954-25-002885 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 10.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 10.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 13 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-13 | 0001641172-25-023572 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 250.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 4.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 4.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 493 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | CommonUnitAuthorized | Common Unit, Authorized | shares | 102,074 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-21 | 0001654954-24-003501 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 |
| us-gaap | ContractuallySpecifiedServicingFeesAmount | Contractually Specified Servicing Fees, Amount | USD | 7.20M | 2025-03-01 | 2025-03-31 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001493152-25-023474 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 |
| us-gaap | ConversionOfStockSharesConverted1 | Conversion of Stock, Shares Converted | shares | 65.82M | 2021-08-01 | 2021-08-17 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 |
| us-gaap | ConvertibleLongTermNotesPayable | Convertible Notes Payable, Noncurrent | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0001654954-22-003869 | |
| us-gaap | ConvertiblePreferredStockConvertedToOtherSecurities | Convertible Preferred Stock Converted to Other Securities | USD | 1.25M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 |
| us-gaap | ConvertibleSubordinatedDebt | Convertible Subordinated Debt | USD | 3.00M | 2020-10-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 | |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 34,008 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | CumulativeEarningsDeficit | Cumulative Earnings (Deficit) | USD | -65.70M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001654954-25-002885 | |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 2.30M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 |
| us-gaap | DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 | Debt Conversion, Converted Instrument, Warrants or Options Issued | shares | 24,106 | 2021-08-01 | 2021-08-17 | 2024 | Q1 | 10-Q | 2024-05-15 | 0001654954-24-006398 |
| us-gaap | DebtInstrumentConvertibleConversionPrice1 | Debt Instrument, Convertible, Conversion Price | USD/shares | 0.8 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001654954-22-015035 | |
| us-gaap | DebtInstrumentFeeAmount | Debt Instrument, Fee Amount | USD | 100,000 | 2021-03-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 | |
| us-gaap | DebtInstrumentPeriodicPaymentPrincipal | Debt Instrument, Periodic Payment, Principal | USD | 231,482 | 2021-01-01 | 2021-02-28 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001654954-22-015035 |
| us-gaap | DeferredFinanceCostsNet | Debt Issuance Costs, Net | USD | 60,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 100,000 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-07 | 0001654954-24-010103 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 4 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 9,736 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 1,091 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001654954-25-002885 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 6,629 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 14.20M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-21 | 0001654954-24-003501 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 71 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsOther | Deferred Tax Assets, Tax Credit Carryforwards, Other | USD | 200,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 1.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 25 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 9,736 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts | Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs | USD | 2.62M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001654954-25-002885 | |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 12,911 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | DepreciationExpenseOnReclassifiedAssets | Depreciation Expense on Reclassified Assets | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0001654954-22-003869 |
| us-gaap | DividendsPreferredStock | Dividends, Preferred Stock | USD | 1.20M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 |
| us-gaap | DividendsPreferredStockStock | Dividends, Preferred Stock, Stock | USD | 269,038 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0001654954-21-012206 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.76 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -2.69 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0001654954-21-012206 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -1.76 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.224 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | pure | 0.021 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | 0.8 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 392,170 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 900,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001654954-25-002885 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 2.21M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-13 | 0001641172-25-023572 |
| us-gaap | GeneralPartnersOfferingCosts | General Partners' Offering Costs | USD | 1.16M | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-07 | 0001654954-24-010103 | |
| us-gaap | GrossProfit | Gross Profit | USD | 40,129 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 950 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 950 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001654954-25-002885 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 1,690 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -1,587 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 15 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -10 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 158 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 1.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -115,829 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 407,195 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001654954-25-002885 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 825,279 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 45,637 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 243,384 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | -121,940 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 |
| us-gaap | InterestExpense | Interest Expense | USD | 0 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-15 | 0001654954-22-011375 |
| us-gaap | InterestExpenseSubordinatedNotesAndDebentures | Interest Expense, Subordinated Notes and Debentures | USD | 180,434 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0001654954-22-006966 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | 161,357 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001654954-23-014016 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 36,216 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-14 | 0001641172-25-010111 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 0 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-15 | 0001654954-22-011375 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 53,639 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 825,279 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | InventoryRawMaterials | Inventory, Raw Materials, Gross | USD | 213,613 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | InventoryWorkInProcess | Inventory, Work in Process, Gross | USD | 558,027 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 162,279 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | LegalFees | Legal Fees | USD | 200,000 | 2026-08-18 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | Liabilities | Liabilities | USD | 2.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 6.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 1.52M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0001654954-22-003869 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0001654954-22-003869 | |
| us-gaap | LossContingencyDamagesPaidValue | Loss Contingency, Damages Paid, Value | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | MalpracticeLossContingencyDiscountRate | Malpractice Loss Contingency, Discount Rate | pure | 0.2 | 2021-01-01 | 2021-01-27 | 2021 | Q2 | 10-Q | 2021-09-27 | 0001654954-21-010437 |
| us-gaap | MarketingExpense | Marketing Expense | USD | 700,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | NetCashProvidedByUsedInContinuingOperations | Net Cash Provided by (Used in) Continuing Operations | USD | 11.10M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001654954-25-002885 |
| us-gaap | NetCashProvidedByUsedInDiscontinuedOperations | Net Cash Provided by (Used in) Discontinued Operations | USD | 7.00M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001654954-22-015035 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 5.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -163,647 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -7.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -7.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -9.61M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 |
| us-gaap | NotesPayable | Notes Payable | USD | 1.15M | 2020-10-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 | |
| us-gaap | NotesPayableRelatedPartiesClassifiedCurrent | Notes Payable, Related Parties, Current | USD | 1.25M | 2021-01-27 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 | |
| us-gaap | NotesPayableRelatedPartiesNoncurrent | Notes Payable, Related Parties, Noncurrent | USD | 311,000 | 2021-01-27 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | OperatingCostsAndExpenses | Operating Costs and Expenses | USD | 9.67M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 7.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -7.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 5.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 | |
| us-gaap | OperatingLossCarryforwardsValuationAllowance | Operating Loss Carryforwards, Valuation Allowance | USD | 9.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 37,499 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | OtherAssets | Other Assets | USD | 45,637 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | OtherExpenses | Other Expenses | USD | 700,000 | 2025-01-01 | 2025-03-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 3.59M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-27 | 0001654954-21-010437 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 86,967 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | OtherResearchAndDevelopmentExpense | Other Research and Development Expense | USD | 7.00M | 2025-01-01 | 2025-03-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | PaymentForManagementFee | Payment for Management Fee | USD | 225,000 | 2021-02-01 | 2021-02-28 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001654954-22-015035 |
| us-gaap | PaymentsOfDerivativeIssuanceCosts | Payments of Derivative Issuance Costs | USD | 70,000 | 2024-01-01 | 2024-06-30 | 2025 | Q2 | 10-Q | 2025-08-13 | 0001641172-25-023572 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 91,352 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 163,647 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 2.29M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0001654954-22-003869 |
| us-gaap | PreferredStockNoParValue | Preferred Stock, No Par Value | USD/shares | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001654954-25-002885 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001493152-26-037127 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001493152-26-037127 | |
| us-gaap | PreferredUnitsIssued | Preferred Units, Issued | shares | 5.22M | 2021-07-30 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 | |
| us-gaap | PrepaidExpenseAndOtherAssets | Prepaid Expense and Other Assets | USD | 100,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 583,314 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 300,124 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | ProceedsFromCollectionOfOtherLoansHeldForSale | Proceeds from Collection of Other Loans Held-for-sale | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0001654954-22-003869 |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 0 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0001654954-22-006966 |
| us-gaap | ProceedsFromFeesReceived | Proceeds from Fees Received | USD | 10.00M | 2021-01-01 | 2021-01-27 | 2021 | Q2 | 10-Q | 2021-09-27 | 0001654954-21-010437 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 3.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 0 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0001654954-22-006966 |
| us-gaap | ProceedsFromIssuanceOfSubordinatedLongTermDebt | Proceeds from Issuance of Subordinated Long-term Debt | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 87 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001654954-22-015035 |
| us-gaap | ProceedsFromLoanOriginations1 | Proceeds from Loan Originations | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0001654954-22-003869 |
| us-gaap | ProceedsFromRepaymentsOfNotesPayable | Proceeds from (Repayments of) Notes Payable | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 |
| us-gaap | ProceedsFromSecuritizationsOfLoansHeldForInvestment | Proceeds from Securitizations of Loans Held-for-investment | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0001654954-22-003869 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 977 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -12.29M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001654954-25-002885 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 169,897 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 158,904 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 12,280 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001654954-22-015035 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 739,581 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 200,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 200,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | RestrictedCashEquivalents | Restricted Cash Equivalents | USD | 3.20M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001654954-25-002885 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -80.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 74,137 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 160,714 | 2021-08-01 | 2021-08-17 | 2023 | Q2 | 10-Q | 2023-08-10 | 0001654954-23-010487 |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 7.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 127,237 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-27 | 0001654954-21-010437 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 398,199 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-27 | 0001654954-21-010437 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | USD | 0 | 2021-01-01 | 2021-03-31 | 2021 | Q2 | 10-Q | 2021-09-27 | 0001654954-21-010437 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.21 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-27 | 0001654954-21-010437 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.009 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-27 | 0001654954-21-010437 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised | shares | 209,915 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-27 | 0001654954-21-010437 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 385 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0001654954-22-015035 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 0 | 2025-07-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001493152-25-023474 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 20,477 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001493152-25-023474 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price | USD/shares | 5.76 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-27 | 0001654954-21-010437 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 5.83 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-27 | 0001654954-21-010437 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-27 | 0001654954-21-010437 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent | Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent | pure | 0.5 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award | shares | 537,750 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-27 | 0001654954-21-010437 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-27 | 0001654954-21-010437 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-27 | 0001654954-21-010437 |
| us-gaap | SharePrice | Share Price | USD/shares | 1.1 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | SharesIssued | Shares, Issued | shares | 15.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | SharesOutstanding | Shares, Outstanding | shares | 1.90M | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-13 | 0001641172-25-023572 | |
| us-gaap | StockGrantedDuringPeriodValueSharebasedCompensation | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture | USD | 1.50M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001493152-26-037127 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 3.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 40 | 2023-01-01 | 2023-03-31 | 2023 | Q2 | 10-Q | 2023-08-10 | 0001654954-23-010487 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 363,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001654954-24-014274 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 3.20M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 1.99M | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 568,372 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0001654954-24-014274 |
| us-gaap | SubordinatedBorrowingInterestRate | Subordinated Borrowing, Interest Rate | pure | 0.04 | 2020-10-01 | 2020-10-31 | 2022 | FY | 10-K | 2023-02-21 | 0001654954-23-001926 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 817 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001654954-25-002885 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 53 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0001654954-25-002885 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 1.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-26 | 0001493152-26-012992 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 4.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 2.95M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-15 | 0001654954-21-012206 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 4.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001493152-26-050967 |